Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2015 | Leisure activities, apolipoprotein E e4 status, and the risk of dementia | Yang S.-Y.; Weng P.-H.; JEN-HAU CHEN ; Chiou J.-M.; Lew-Ting C.-Y.; TA-FU CHEN ; Sun Y.; Wen L.-L.; Yip P.-K.; Chu Y.-M.; YEN-CHING CHEN | Journal of the Formosan Medical Association | 16 | 14 | |
2006 | Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area | WEI-LIANG SHIH ; MING-WHEI YU ; PEI-JER CHEN ; Shiou-Hwei Yeh ; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; CHUHSING KATE HSIAO ; Yang S.-Y.; Chen C.-J. | Oncogene | 17 | 14 | |
2019 | Long-Term Storage Effects on Stability of Aβ1-40, Aβ1-42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays | MING-JANG CHIU ; Lue L.-F.; Sabbagh M.N.; TA-FU CHEN ; Chen H.H.; Yang S.-Y. | Dementia and Geriatric Cognitive Disorders Extra | 15 | 13 | |
2011 | Low-Field nuclear magnetic resonance and magnetic resonance imaging using a high-tc squid for tumor detection | KAI-WEN HUANG ; Liao S.-H.; Yang H.-C.; Chen H.-H.; Horng H.-E.; Chen M.J.; Yang S.-Y. | IEEE Transactions on Applied Superconductivity | 4 | 4 | |
2018 | Mass-size distribution and concentration of metals from personal exposure to arc welding fume in pipeline construction: A case report | Yang S.-Y.; Lin J.-M.; Young L.-H.; CHING-WEN CHANG | Industrial Health | 8 | 7 | |
2020 | Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study | MING-JANG CHIU ; TA-FU CHEN ; Hu C.-J.; Yan S.-H.; Sun Y.; Liu B.-H.; Chang Y.-T.; Yang C.-C.; Yang S.-Y. | Nanomedicine: Nanotechnology, Biology, and Medicine | 21 | 19 | |
1999 | A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers | MING-WHEI YU ; Yang S.-Y.; Chiu Y.-H.; Chiang Y.-C.; Liaw Y.-F.; Chen C.-J. | Hepatology | 136 | 120 | |
2014 | Patient- and clinic visit-related factors associated with potentially inappropriate medication use among older home healthcare service recipients | CHIRN-BIN CHANG ; Lai H.-Y.; Yang S.-Y.; Wu R.-S.; Liu H.-C.; Hsu H.-Y.; Hwang S.-J.; DING-CHENG CHAN | PLoS ONE | 35 | 28 | |
2018 | Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease | Teunissen C.E.; MING-JANG CHIU ; Yang C.-C.; Yang S.-Y.; Scheltens P.; Zetterberg H.; Blennow K. | Journal of Alzheimer's disease : JAD | 100 | 88 | |
2014 | Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease | KAI-YUAN TZEN ; Yang S.-Y.; TA-FU CHEN ; Cheng T.-W.; Horng H.-E.; Wen H.-P.; Huang Y.-Y.; Shiue C.-Y.; MING-JANG CHIU | ACS Chemical Neuroscience | 87 | 86 | |
2018 | Plasma biomarkers differentiate Parkinson's disease from atypical parkinsonism syndromes | CHIN-HSIEN LIN ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; MING-JANG CHIU | Frontiers in Aging Neuroscience | 41 | 36 | |
2017 | Plasma levels of Aβ42 and Tau identified probable Alzheimer's dementia: Findings in two cohorts | Lue L.-F.; MING-JANG CHIU et al. ; Chiu M.-J.; Jing N.; Snyder N.L.; Schmitz C.; Guerra A.; Belden C.M.; TA-FU CHEN ; Yang C.-C.; Yang S.-Y.; Walker D.G.; Chen K.; Reiman E.M. | Frontiers in Aging Neuroscience | 80 | 75 | |
2019 | Plasma ps129-α-synuclein is a surrogate biofluid marker of motor severity and progression in parkinson's disease | CHIN-HSIEN LIN ; Liu H.-C.; Yang S.-Y.; KAI-CHIEN YANG ; CHAU-CHUNG WU ; MING-JANG CHIU | Journal of Clinical Medicine | 20 | 17 | |
2014 | Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease | MING-JANG CHIU ; YA-FANG CHEN ; TA-FU CHEN ; Yang S.-Y.; Yang F.-P.G.; Tseng T.-W.; Chieh J.-J.; Chen J.-C.R.; KAI-YUAN TZEN ; Hua M.-S.; Horng H.-E. | Human Brain Mapping | 116 | 106 | |
2017 | Plasma α-synuclein predicts cognitive decline in Parkinson's disease | CHIN-HSIEN LIN ; Yang S.-Y.; Horng H.-E.; Yang C.-C.; Chieh J.-J.; Chen H.-H.; Liu B.-H.; MING-JANG CHIU | Journal of Neurology, Neurosurgery and Psychiatry | 113 | 99 | |
2018 | Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment | SUNG-CHUN TANG ; KAI-CHIEN YANG ; CHIH-HAO CHEN ; Yang S.-Y.; MING-JANG CHIU ; CHAU-CHUNG WU ; JIANN-SHING JENG | NeuroMolecular Medicine | 16 | 16 | |
2011 | Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery | JANG-MING LEE ; Yang S.-Y.; Yang P.-W.; CHIA-TUNG SHUN ; Wu M.-T.; CHIH-HUNG HSU ; CHIA-CHI LIN ; CHIA-HSIEN CHENG ; Wang Y.-H.; Chuang T.-H.; JIN-SHING CHEN ; HSAO-HSUN HSU ; PEI-MING HUANG ; SHUENN-WEN KUO ; Lee Y.-C. | Annals of Surgical Oncology | 21 | 19 | |
2003 | Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma | MING-WHEI YU ; Yang S.-Y.; Pan I.-J.; Lin C.-L.; CHUN-JEN LIU ; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN ; Lee S.-D.; Chen C.-J. | Journal of the National Cancer Institute | 107 | 95 | |
2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
2018 | Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics | Yang S.-Y.; LIAN-YU CHEN ; Najoan E.; Kallivayalil R.A.; Viboonma K.; Jamaluddin R.; Javed A.; Hoa D.T.Q.; Iida H.; Sim K.; Swe T.; He Y.-L.; Park Y.; Ahmed H.U.; De Alwis A.; Chiu H.F.-K.; Sartorius N.; Tan C.-H.; Chong M.-Y.; Shinfuku N.; Lin S.-K. | Psychiatry and Clinical Neurosciences | 42 | 35 | |